41.540 articles found

Endosomal Recycling Defects and Neurodevelopmental Disorders.

Saitoh S.

Cells · 2022-01-03

DOI: 10.3390/cells11010148PMID: 35011709

Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination.

Kaur R, Singh S, Singh TG, Sood P, Robert J.

Inflammopharmacology · 2022-01-03

DOI: 10.1007/s10787-021-00904-wPMID: 34981320

Pumpentherapie bei fortgeschrittenem Parkinson-Syndrom : Charakterisierung des Intestinalgels Levodopa-Entacapon-Carbidopa

H. Jost W, Fokkens J.

DNP – Die Neurologie & Psychiatrie · 2022-01-01

Speech and language therapy interventions for speech problems in Parkinson's disease

Campbell P, Rooney S, Nicoll A, Brady M, Smith C, Deane K, Herd C, Tomlinson C, Clarke C, Sackley C.

The Cochrane database of systematic reviews · 2022-01-01

Systematic enhancement of L-DOPA and Secondary metabolites from Mucuna imbricata: Implication of precursors and elicitors in Callus culture

Suryawanshi S, Kshirsagar P, Kamble P, Bapat V, Jadhav J.

South African journal of botany : official journal of the South African Association of Botanists = Suid-Afrikaanse tydskrif vir plantkunde : amptelike tydskrif van die Suid-Afrikaanse Genootskap van Plantkundiges · 2022-01-01

Engineered Probiotic and Prebiotic Nutraceutical Supplementations in Combating Non-communicable Disorders: A Review.

Kerry RG, Das G, Golla U, Del Pilar Rodriguez-Torres M, Shin HS, Patra JK.

Curr Pharm Biotechnol · 2022-01-01

DOI: 10.2174/1389201021666201013153142PMID: 33050862

Persons with Co-Existing Neurological Disorders: Risk Analysis, Considerations and Management in COVID-19 Pandemic.

Sharma S, Batra S, Gupta S, Sharma VK, Rahman MH, Kamal MA.

CNS Neurol Disord Drug Targets · 2022-01-01

DOI: 10.2174/1871527320666210308113457PMID: 33687889

Neural Basis of Dental Pulp Stem Cells and its Potential Application in Parkinson's Disease.

Sharma Y, Shobha K, Sundeep M, Pinnelli VB, Parveen S, Dhanushkodi A.

CNS Neurol Disord Drug Targets · 2022-01-01

DOI: 10.2174/1871527320666210311122921PMID: 33719979

Antioxidant Activity of 1,2,4-Triazole and its Derivatives: A Mini-Review.

Pachuta-Stec A.

Mini Rev Med Chem · 2022-01-01

DOI: 10.2174/1389557521666210401091802PMID: 33797373

Do Naturally Occurring Antioxidants Protect Against Neurodegeneration of the Dopaminergic System? A Systematic Revision in Animal Models of Parkinson's Disease.

Costas C, Faro LRF.

Curr Neuropharmacol · 2022-01-01

DOI: 10.2174/1570159x19666210421092725PMID: 33882808

The intestinal luminal sources of α-synuclein: a gastroenterologist perspective.

Lerner A.

Nutr Rev · 2022-01-01

DOI: 10.1093/nutrit/nuab024PMID: 33942062

Arachidonic Acid Metabolites in Neurologic Disorders.

Kursun O, Karatas H, Bariskaner H, Ozturk S.

CNS Neurol Disord Drug Targets · 2022-01-01

DOI: 10.2174/1871527320666210512013648PMID: 33982658